Sponsors & CROs

At Valiance Clinical Research, we go beyond conducting trials—we cultivate trusted partnerships that shape the future of medicine. Every patient we support and every insight we uncover is driven by our unwavering commitment to advancing healthcare in meaningful ways. Grounded in scientific excellence and guided by compassion, we strive to create real-world change responsibly and ethically.

Transformative Research

Collaborating with clients, Valiance conducts clinical studies across all phases of research and discovery, development, validation and approval.  We add value across the full spectrum of clinical trials from fast and easy startups, dedicated recruitment staff for quick enrollment and retention, to capturing, reporting, and entering valuable data across applicable data capture systems.

Sponsors CROs second img

Sponsors & CROs

11
10
44
29
26
14
9
33
43
19
38
31
41
34
37
36
22
13
12
21
5
24
45
42
15
16
30
7
8

Turn insight into impact

To that end, our capacity and capabilities encompass the following:  

Flexible | Scalable

  • Phase 1 – Phase 4 clinical trials
  • Full Time Board Certified Physicians
  • Full Time Board Certified Nurse Practitioners
  • Full Time Clinical Research Coordinators
  • Double locked, secured and monitored I.P and Document storage
  • Medical Imaging Capabilities – Ultrasound, X-Ray, CT-Scan, Endoscopy and more
  • Dedicated Monitoring Space

Secure | Controlled

  • Calibrated/Secured -70°c Freezers
  • Calibrated/Secured -20°c Freezer
  • Calibrated/Secured 2-8°c Refrigerator
  • Calibrated/Secured Ambient storage
  • Calibrated Ambient and refrigerated centrifuge
  • 24/7 Current/Min/Max Investigational Product and sample temperature monitoring
  • Calibrated Blood Pressure Monitoring Devices
  • Calibrated Electrocardiogram Machines

Accessible | Equipped | Patient-Centered

  • Multiple Private Patient Rooms
  • Private Conference Rooms
  • Secure and Encrypted Wifi, Fax, Copy, Printer, and Scanners for Sponsor/CRO use
  • Dedicated Monitoring Space
  • Uber Health for Patient Transportation
  • Subject stipends distributed immediately after each completed visit via visa cards
  • Flexible schedules, including after hours and weekends
  • Bilingual staff, including, but not limited to: Spanish, Tagalog, Farsi, Cantonese, Korean, Armenian and English

Study Start Up Process

Health research tests new treatments through clinical trials. Learn what’s involved.

CDA  2-3 Days

We begin by sharing essential details about the study, what it’s trying to achieve, the treatment being tested, how long it lasts, and what your involvement might look like. You'll have time to ask questions and see if the trial is a good fit for you.

Feasibility Questionaire 2-4 Days

If you're interested in moving forward, we’ll provide a consent form that clearly explains everything, your rights, what’s expected of you, and any potential risks or benefits. There’s no pressure. You’re free to take your time, and even if you sign, you can withdraw at any point. Your comfort always comes first.

Budget/Contract/
Regulatory All Done in Parallel

Next, we review your health history and may conduct a few tests to ensure the study is right for you. Every clinical trial has specific guidelines, and we take care to match participants carefully for their safety and the integrity of the research.

Site activation 8-12 Weeks From the Time of CDA

Once you're enrolled, you'll begin the trial. This may involve regular check-ins, health assessments, or treatment sessions, all designed with your safety and care in mind. Our team will support you closely throughout the process.

First Patient Screened 24-48hrs from activation

When the study ends, so does your active participation, but our connection doesn’t stop there. We’re here to answer follow-up questions, share what we can about the trial’s outcomes,and make sure you feel recognized and appreciated for the role you played in advancing science.

Reach. Retention. Results.

It is important that culturally and linguistically diverse people have access to clinical research to ensure that the evidence gathered is applicable to them. We know that there are potential factors such as racial differences in opioid receptors, cultural expression of pain, interaction with healthcare professionals, perception of interventions or hospital admission that may impact this.  This is why it’s critical to have diverse representation in clinical trials – to better understand patient differences that may affect clinical outcomes.  Our patient demographics consist of the following:

46.9%

Hispanic or Latino: 46.9% of the population

28.9% 

White (non-Hispanic): 28.9% of the populationn

11.7%

Asian: 11.7% of the Local population

11.7%

African American: 8.3% of the population

3.3%

Two or more races: 3.3% of the population

0.7%

Other: 0.7% of the local population

Sponsors CROs 3 img

Advancing Therapeutics, Transforming Outcomes

Failure to meet enrollment targets or population diversity can compromise data quality and regulatory acceptance. Our sites achieve a 97% retention rate through frequent check-ins, text reminders, and personalized engagement. We meet 98% of enrollment goals, with 80% from internal databases, 10% from referrals, 5% from community events, and 5% from digital marketing.

Targeted Solutions to Enhance Patient Care

We utilize our deep medical expertise and insights into gaps in patient care to help develop cutting-edge therapies and innovative solutions. By focusing on essential therapeutic areas, we aim to address complex diseases and expand treatment options, ultimately enhancing patient outcomes and improving quality of life.  These therapeutic areas are the following:

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Neurology

Meet Our Team

Our expert teams work closely with sponsors to tailor the best solution for each project.

Rectangle 20 2

Dr. David Lee

Study Coordinator

Rectangle 20 1 1

Dr. Gail Ma

Study Coordinator

Rectangle 20 2

Dr. Richard Park

Internal Medicine

Rectangle 20 2 1

Dr. Eleanor Azurin

Family Medicine

Rectangle 20 2

Dr. Rami Shaarawy

Internal Medicine/
Pulmonology

Rectangle 20 2

Dr. David Lee

Study Coordinator

Rectangle 20 2

Dr. David Lee

Study Coordinator

Rectangle 20 2

Dr. David Lee

Study Coordinator

Rectangle 20 2

Dr. David Lee

Study Coordinator

Sponsor A Study

We have expertise in conducting clinical trials and the efficacy of treatment for a wide range of conditions. 

smiling scientists looking camera 13339 115210